Beyond Air, Inc. Research and Development in Process
Beyond Air, Inc. (XAIR) reported Research and Development in Process of $56.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2018-08-14
- Beyond Air, Inc. research and development in process for the quarter ending 2018-06-30 was $56.00K.
- Beyond Air, Inc. research and development in process for the quarter ending 2017-12-31 was $0.00.
- Beyond Air, Inc. research and development in process for the quarter ending 2017-09-30 was $0.00.
- Beyond Air, Inc. research and development in process for the quarter ending 2017-06-30 was $0.00.
- Beyond Air, Inc. research and development in process for fiscal 2017 was $480.00K.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2018-06-30 | $56.00K 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15 | $0.00 derived: sum of 2 quarters · filed 2018-06-15 | $0.00 derived: sum of 3 quarters · filed 2018-06-15 | $480.00K 10-KT · filed 2018-06-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-03 | $480.00K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $480.00K 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | $480.00K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |